Amedeo Smart

Free Medical Literature Service



Breast Cancer

  Free Subscription

Articles published in
PLoS One
    January 2018
  1. OLIVEIRA MMF, Gurgel MSC, Amorim BJ, Ramos CD, et al
    Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial.
    PLoS One. 2018;13:e0189176.
    >> Share

  2. THAKUR SS, Li H, Chan AMY, Tudor R, et al
    The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
    PLoS One. 2018;13:e0188983.
    >> Share

  3. SANNACHI L, Gangeh M, Tadayyon H, Sadeghi-Naini A, et al
    Response monitoring of breast cancer patients receiving neoadjuvant chemotherapy using quantitative ultrasound, texture, and molecular features.
    PLoS One. 2018;13:e0189634.
    >> Share

  4. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2018;13:e0190814.
    >> Share

  5. KROIGARD AB, Larsen MJ, Laenkholm AV, Knoop AS, et al
    Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.
    PLoS One. 2018;13:e0189887.
    >> Share

  6. BROMBERG SE, Moraes PRAF, Ades F
    Prime incision: A minimally invasive approach to breast cancer surgical treatment-A 2 cohort retrospective comparison with conventional breast conserving surgery.
    PLoS One. 2018;13:e0191056.
    >> Share

  7. HILDENBRAND G, Metzler P, Pilarczyk G, Bobu V, et al
    Dose enhancement effects of gold nanoparticles specifically targeting RNA in breast cancer cells.
    PLoS One. 2018;13:e0190183.
    >> Share

  8. LI T, Zhao J, Yang J, Ma X, et al
    Correction: A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    PLoS One. 2018;13:e0191579.
    >> Share

  9. KHALIS M, Charbotel B, Chajes V, Rinaldi S, et al
    Menstrual and reproductive factors and risk of breast cancer: A case-control study in the Fez region, Morocco.
    PLoS One. 2018;13:e0191333.
    >> Share

  10. TSAI HP, Huang SF, Li CF, Chien HT, et al
    Differential microRNA expression in breast cancer with different onset age.
    PLoS One. 2018;13:e0191195.
    >> Share

  11. SYED BM, Morgan D, Setty T, Green AR, et al
    Correction: Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2018;13:e0191979.
    >> Share

  12. KIM J, Choi SH, Ham SJ, Cho YC, et al
    Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model.
    PLoS One. 2018;13:e0187063.
    >> Share

  13. BOUGARET L, Delort L, Billard H, Le Huede C, et al
    Adipocyte/breast cancer cell crosstalk in obesity interferes with the anti-proliferative efficacy of tamoxifen.
    PLoS One. 2018;13:e0191571.
    >> Share

  14. KHAN MM, Mendes A, Chalup SK
    Evolutionary Wavelet Neural Network ensembles for breast cancer and Parkinson's disease prediction.
    PLoS One. 2018;13:e0192192.
    >> Share

  15. RUSSO-ABRAHAO T, Lacerda-Abreu MA, Gomes T, Cosentino-Gomes D, et al
    Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231.
    PLoS One. 2018;13:e0191270.
    >> Share

  16. BELCHER DA, Ju JA, Baek JH, Yalamanoglu A, et al
    The quaternary state of polymerized human hemoglobin regulates oxygenation of breast cancer solid tumors: A theoretical and experimental study.
    PLoS One. 2018;13:e0191275.
    >> Share

  17. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Correction: Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2018;13:e0192589.
    >> Share

  18. ZHANG J, Yang J, Zhang X, Xu J, et al
    MicroRNA-10b expression in breast cancer and its clinical association.
    PLoS One. 2018;13:e0192509.
    >> Share

  19. JOFFE M, Ayeni O, Norris SA, McCormack VA, et al
    Barriers to early presentation of breast cancer among women in Soweto, South Africa.
    PLoS One. 2018;13:e0192071.
    >> Share

  20. PATEL N, Garikapati KR, Makani VKK, Nair AD, et al
    Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
    PLoS One. 2018;13:e0190245.
    >> Share

  21. VACHER S, Castagnet P, Chemlali W, Lallemand F, et al
    High AHR expression in breast tumors correlates with expression of genes from several signaling pathways namely inflammation and endogenous tryptophan metabolism.
    PLoS One. 2018;13:e0190619.
    >> Share

  22. THAKRAN S, Chatterjee S, Singhal M, Gupta RK, et al
    Automatic outer and inner breast tissue segmentation using multi-parametric MRI images of breast tumor patients.
    PLoS One. 2018;13:e0190348.
    >> Share

  23. CALA MP, Aldana J, Medina J, Sanchez J, et al
    Multiplatform plasma metabolic and lipid fingerprinting of breast cancer: A pilot control-case study in Colombian Hispanic women.
    PLoS One. 2018;13:e0190958.
    >> Share

  24. ROHAN T, Ye K, Wang Y, Glass AG, et al
    MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer.
    PLoS One. 2018;13:e0191814.
    >> Share

  25. YUAN H, Chen V, Boisvert M, Isaacs C, et al
    PLAC1 as a serum biomarker for breast cancer.
    PLoS One. 2018;13:e0192106.
    >> Share

  26. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    >> Share

  27. HO PJ, Hartman M, Young-Afat DA, Gernaat SAM, et al
    Determinants of satisfaction with cosmetic outcome in breast cancer survivors: A cross-sectional study.
    PLoS One. 2018;13:e0193099.
    >> Share

  28. JENSEN-JOHANSEN MB, O'Toole MS, Christensen S, Valdimarsdottir H, et al
    Expressive writing intervention and self-reported physical health out-comes - Results from a nationwide randomized controlled trial with breast cancer patients.
    PLoS One. 2018;13:e0192729.
    >> Share

  29. DE GROEF A, Van Kampen M, Moortgat P, Anthonissen M, et al
    An evaluation tool for Myofascial Adhesions in Patients after Breast Cancer (MAP-BC evaluation tool): Concurrent, face and content validity.
    PLoS One. 2018;13:e0193915.
    >> Share

  30. BOSE C, Awasthi S, Sharma R, Benes H, et al
    Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model.
    PLoS One. 2018;13:e0193918.
    >> Share

  31. HUSSAIN A, Yong C, Tkaczuk KHR, Qian Y, et al
    Prevalence and risk of skeletal complications and use of radiation therapy in elderly women diagnosed with metastatic breast cancer.
    PLoS One. 2018;13:e0193661.
    >> Share

  32. ALMOTWAA S, Elrobh M, AbdulKarim H, Alanazi M, et al
    Genetic polymorphism and expression of HSF1 gene is significantly associated with breast cancer in Saudi females.
    PLoS One. 2018;13:e0193095.
    >> Share

  33. VREEMANN S, Gubern-Merida A, Borelli C, Bult P, et al
    The correlation of background parenchymal enhancement in the contralateral breast with patient and tumor characteristics of MRI-screen detected breast cancers.
    PLoS One. 2018;13:e0191399.
    >> Share

  34. LAGUNIN AA, Dubovskaja VI, Rudik AV, Pogodin PV, et al
    CLC-Pred: A freely available web-service for in silico prediction of human cell line cytotoxicity for drug-like compounds.
    PLoS One. 2018;13:e0191838.
    >> Share

    January 2017
  35. ROCHA-BRISCHILIARI SC, Oliveira RR, Andrade L, Brischiliari A, et al
    The Rise in Mortality from Breast Cancer in Young Women: Trend Analysis in Brazil.
    PLoS One. 2017;12:e0168950.
    >> Share

  36. WANG K, Ren Y, He J
    Cavity Shaving plus Lumpectomy versus Lumpectomy Alone for Patients with Breast Cancer Undergoing Breast-Conserving Surgery: A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0168705.
    >> Share

  37. WU W, Ma J, Shao N, Shi Y, et al
    Co-Targeting IGF-1R and Autophagy Enhances the Effects of Cell Growth Suppression and Apoptosis Induced by the IGF-1R Inhibitor NVP-AEW541 in Triple-Negative Breast Cancer Cells.
    PLoS One. 2017;12:e0169229.
    >> Share

  38. CHEN Q, Weng Z, Lu Y, Jia Y, et al
    An Experimental Analysis of the Molecular Effects of Trastuzumab (Herceptin) and Fulvestrant (Falsodex), as Single Agents or in Combination, on Human HR+/HER2+ Breast Cancer Cell Lines and Mouse Tumor Xenografts.
    PLoS One. 2017;12:e0168960.
    >> Share

  39. MAKHOUL I, Todorova VK, Siegel ER, Erickson SW, et al
    Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
    PLoS One. 2017;12:e0168550.
    >> Share

  40. DIAS K, Dvorkin-Gheva A, Hallett RM, Wu Y, et al
    Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.
    PLoS One. 2017;12:e0168669.
    >> Share

  41. LIU Y, Zhang Y, Li Q, Li J, et al
    MiRNAs Predict the Prognosis of Patients with Triple Negative Breast Cancer: A Meta-Analysis.
    PLoS One. 2017;12:e0170088.
    >> Share

  42. SINHA AK, Patel JR, Shen Y, Ueno NT, et al
    Location of Receipt of Initial Treatment and Outcomes in Long-Term Breast Cancer Survivors.
    PLoS One. 2017;12:e0170081.
    >> Share

  43. VITALI F, Cohen LD, Demartini A, Amato A, et al
    Correction: A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    PLoS One. 2017;12:e0170363.
    >> Share

  44. BRONSVELD HK, Jensen V, Vahl P, De Bruin ML, et al
    Diabetes and Breast Cancer Subtypes.
    PLoS One. 2017;12:e0170084.
    >> Share

  45. KIM YC, Soliman AS, Cui J, Ramadan M, et al
    Unique Features of Germline Variation in Five Egyptian Familial Breast Cancer Families Revealed by Exome Sequencing.
    PLoS One. 2017;12:e0167581.
    >> Share

  46. SINGH A, Sharma RK, Chagtoo M, Agarwal G, et al
    1H NMR Metabolomics Reveals Association of High Expression of Inositol 1, 4, 5 Trisphosphate Receptor and Metabolites in Breast Cancer Patients.
    PLoS One. 2017;12:e0169330.
    >> Share

  47. HATOUM D, Yagoub D, Ahadi A, Nassif NT, et al
    Annexin/S100A Protein Family Regulation through p14ARF-p53 Activation: A Role in Cell Survival and Predicting Treatment Outcomes in Breast Cancer.
    PLoS One. 2017;12:e0169925.
    >> Share

  48. LI Y, Wang J, Lin F, Yang Y, et al
    A Methodology for Cancer Therapeutics by Systems Pharmacology-Based Analysis: A Case Study on Breast Cancer-Related Traditional Chinese Medicines.
    PLoS One. 2017;12:e0169363.
    >> Share

  49. HUANG MW, Chen CW, Lin WC, Ke SW, et al
    SVM and SVM Ensembles in Breast Cancer Prediction.
    PLoS One. 2017;12:e0161501.
    >> Share

  50. THIRUKKUMARAN C, Shi ZQ, Thirukkumaran P, Luider J, et al
    PUMA and NF-kB Are Cell Signaling Predictors of Reovirus Oncolysis of Breast Cancer.
    PLoS One. 2017;12:e0168233.
    >> Share

  51. PILLAI SG, Zhu P, Siddappa CM, Adams DL, et al
    Enrichment and Molecular Analysis of Breast Cancer Disseminated Tumor Cells from Bone Marrow Using Microfiltration.
    PLoS One. 2017;12:e0170761.
    >> Share

  52. PETERS IT, van Zwet EW, Smit VT, Liefers GJ, et al
    Prevalence and Risk Factors of Ovarian Metastases in Breast Cancer Patients < 41 Years of Age in the Netherlands: A Nationwide Retrospective Cohort Study.
    PLoS One. 2017;12:e0168277.
    >> Share

  53. SIGLEY J, Jarzen J, Scarpinato K, Guthold M, et al
    Diffusion and Binding of Mismatch Repair Protein, MSH2, in Breast Cancer Cells at Different Stages of Neoplastic Transformation.
    PLoS One. 2017;12:e0170414.
    >> Share

  54. DENG J, Yang M, Jiang R, An N, et al
    Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
    PLoS One. 2017;12:e0170860.
    >> Share

  55. YIN K, Liu Y, Chu M, Wang Y, et al
    TFDP3 Regulates Epithelial-Mesenchymal Transition in Breast Cancer.
    PLoS One. 2017;12:e0170573.
    >> Share

  56. DALM SU, Schrijver WA, Sieuwerts AM, Look MP, et al
    Prospects of Targeting the Gastrin Releasing Peptide Receptor and Somatostatin Receptor 2 for Nuclear Imaging and Therapy in Metastatic Breast Cancer.
    PLoS One. 2017;12:e0170536.
    >> Share

  57. PIRES BR, Mencalha AL, Ferreira GM, de Souza WF, et al
    NF-kappaB Is Involved in the Regulation of EMT Genes in Breast Cancer Cells.
    PLoS One. 2017;12:e0169622.
    >> Share

  58. ZIV E, Tice JA, Sprague B, Vachon CM, et al
    Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention.
    PLoS One. 2017;12:e0168601.
    >> Share

  59. LINDBERG P, Netter P, Koller M, Steinger B, et al
    Breast cancer survivors` recollection of their quality of life: Identifying determinants of recall bias in a longitudinal population-based trial.
    PLoS One. 2017;12:e0171519.
    >> Share

  60. STRUMYLAITE L, Kregzdyte R, Poskiene L, Bogusevicius A, et al
    Association between lifetime exposure to passive smoking and risk of breast cancer subtypes defined by hormone receptor status among non-smoking Caucasian women.
    PLoS One. 2017;12:e0171198.
    >> Share

  61. KIM TH, Chang JS, Park KS, Park J, et al
    Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial.
    PLoS One. 2017;12:e0171771.
    >> Share

  62. BALEKOUZOU A, Yin P, Afewerky HK, Bekolo C, et al
    Behavioral risk factors of breast cancer in Bangui of Central African Republic: A retrospective case-control study.
    PLoS One. 2017;12:e0171154.
    >> Share

  63. AZIZ S, Wik E, Knutsvik G, Klingen TA, et al
    Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancer.
    PLoS One. 2017;12:e0171853.
    >> Share

  64. GOMES-ROCHETTE NF, Souza LS, Tommasi BO, Pedrosa DF, et al
    Association of PvuII and XbaI polymorphisms on estrogen receptor alpha (ESR1) gene to changes into serum lipid profile of post-menopausal women: Effects of aging, body mass index and breast cancer incidence.
    PLoS One. 2017;12:e0169266.
    >> Share

  65. AUGUSTE A, Cortet M, Dabakuyo-Yonli TS, Launay L, et al
    Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.
    PLoS One. 2017;12:e0170069.
    >> Share

  66. HUANG NS, Quan CL, Mo M, Chen JJ, et al
    A prospective study of breast anthropomorphic measurements, volume and ptosis in 605 Asian patients with breast cancer or benign breast disease.
    PLoS One. 2017;12:e0172122.
    >> Share

  67. AKUOKO CP, Armah E, Sarpong T, Quansah DY, et al
    Barriers to early presentation and diagnosis of breast cancer among African women living in sub-Saharan Africa.
    PLoS One. 2017;12:e0171024.
    >> Share

  68. TERRENATO I, D'Alicandro V, Casini B, Perracchio L, et al
    A cut-off of 2150 cytokeratin 19 mRNA copy number in sentinel lymph node may be a powerful predictor of non-sentinel lymph node status in breast cancer patients.
    PLoS One. 2017;12:e0171517.
    >> Share

  69. JANG MH, Kim HJ, Chung YR, Lee Y, et al
    A comparison of Ki-67 counting methods in luminal Breast Cancer: The Average Method vs. the Hot Spot Method.
    PLoS One. 2017;12:e0172031.
    >> Share

  70. CONTE F, Fiscon G, Chiara M, Colombo T, et al
    Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
    PLoS One. 2017;12:e0171661.
    >> Share

  71. KASHIWAGI S, Asano Y, Goto W, Takada K, et al
    Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
    PLoS One. 2017;12:e0170634.
    >> Share

  72. FAN M, Li H, Wang S, Zheng B, et al
    Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.
    PLoS One. 2017;12:e0171683.
    >> Share

  73. TAKEDA T, Yamamoto H, Kanzaki H, Suzawa K, et al
    Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLoS One. 2017;12:e0171356.
    >> Share

  74. SIEUWERTS AM, Schrijver WA, Dalm SU, de Weerd V, et al
    Progressive APOBEC3B mRNA expression in distant breast cancer metastases.
    PLoS One. 2017;12:e0171343.
    >> Share

  75. QIAN XL, Zhang J, Li PZ, Lang RG, et al
    Dasatinib inhibits c-src phosphorylation and prevents the proliferation of Triple-Negative Breast Cancer (TNBC) cells which overexpress Syndecan-Binding Protein (SDCBP).
    PLoS One. 2017;12:e0171169.
    >> Share

  76. QIAO W, Pan L, Kou C, Li K, et al
    Prognostic and clinicopathological value of poly (adenosine diphosphate-ribose) polymerase expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0172413.
    >> Share

  77. KIM MH, Lee KY, Park S, Kim SI, et al
    Effects of systemic lidocaine versus magnesium administration on postoperative functional recovery and chronic pain in patients undergoing breast cancer surgery: A prospective, randomized, double-blind, comparative clinical trial.
    PLoS One. 2017;12:e0173026.
    >> Share

  78. GSCHWANTLER-KAULICH D, Tan YY, Fuchs EM, Hudelist G, et al
    PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer.
    PLoS One. 2017;12:e0172911.
    >> Share

  79. CLARKE CS, Hunter RM, Shemilt I, Serra-Sastre V, et al
    Multi-arm Cost-Effectiveness Analysis (CEA) comparing different durations of adjuvant trastuzumab in early breast cancer, from the English NHS payer perspective.
    PLoS One. 2017;12:e0172731.
    >> Share

  80. CHUNG IY, Lee JW, Lee JS, Park YR, et al
    Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer.
    PLoS One. 2017;12:e0170311.
    >> Share

  81. KAN-DAPAAH K, Rahbar N, Soboyejo W
    Polymeric composite devices for localized treatment of early-stage breast cancer.
    PLoS One. 2017;12:e0172542.
    >> Share

  82. ISLAM S, Dasgupta H, Roychowdhury A, Bhattacharya R, et al
    Study of association and molecular analysis of human papillomavirus in breast cancer of Indian patients: Clinical and prognostic implication.
    PLoS One. 2017;12:e0172760.
    >> Share

  83. SIMON M, Mesmar F, Helguero L, Williams C, et al
    Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant.
    PLoS One. 2017;12:e0172832.
    >> Share

  84. PAN Y, Yuan Y, Liu G, Wei Y, et al
    P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients.
    PLoS One. 2017;12:e0172324.
    >> Share

  85. CURRY A, Khatri I, Kos O, Zhu F, et al
    Importance of CD200 expression by tumor or host cells to regulation of immunotherapy in a mouse breast cancer model.
    PLoS One. 2017;12:e0171586.
    >> Share

  86. LEE J, Kim HH, Ro SM, Yang JH, et al
    Capecitabine and cisplatin (XP) combination systemic chemotherapy in heavily pre-treated HER2 negative metastatic breast cancer.
    PLoS One. 2017;12:e0171605.
    >> Share

  87. SON SH, Choi KH, Kim SW
    Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer.
    PLoS One. 2017;12:e0173552.
    >> Share

  88. MENNING S, de Ruiter MB, Veltman DJ, Boogerd W, et al
    Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    PLoS One. 2017;12:e0171724.
    >> Share

  89. ZAK M, Biskup M, Macek P, Krol H, et al
    Identifying predictive motor factors for falls in post-menopausal breast cancer survivors.
    PLoS One. 2017;12:e0173970.
    >> Share

  90. TOSCANI AM, Sampayo RG, Barabas FM, Fuentes F, et al
    Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models.
    PLoS One. 2017;12:e0174230.
    >> Share

  91. Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.
    PLoS One. 2017;12:e0174493.
    >> Share

  92. HENG J, Guo X, Wu W, Wang Y, et al
    Integrated analysis of promoter mutation, methylation and expression of AKT1 gene in Chinese breast cancer patients.
    PLoS One. 2017;12:e0174022.
    >> Share

  93. HE X, Ye F, Zhao B, Tang H, et al
    Risk factors for delay of adjuvant chemotherapy in non-metastatic breast cancer patients: A systematic review and meta-analysis involving 186982 patients.
    PLoS One. 2017;12:e0173862.
    >> Share

  94. KLEBANER D, Hamilton-Dutoit S, Ahern T, Crawford A, et al
    Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients.
    PLoS One. 2017;12:e0171453.
    >> Share

  95. NG CG, Mohamed S, Kaur K, Sulaiman AH, et al
    Perceived distress and its association with depression and anxiety in breast cancer patients.
    PLoS One. 2017;12:e0172975.
    >> Share

  96. LIU Y, Gu F, Liang J, Dai X, et al
    The efficacy and toxicity profile of metronomic chemotherapy for metastatic breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0173693.
    >> Share

  97. AZAD AK, Lawen A, Keith JM
    Bayesian model of signal rewiring reveals mechanisms of gene dysregulation in acquired drug resistance in breast cancer.
    PLoS One. 2017;12:e0173331.
    >> Share

  98. SHEN CJ, Kuo YL, Chen CC, Chen MJ, et al
    MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer.
    PLoS One. 2017;12:e0174487.
    >> Share

  99. LEE J, Hong BS, Ryu HS, Lee HB, et al
    Transition into inflammatory cancer-associated adipocytes in breast cancer microenvironment requires microRNA regulatory mechanism.
    PLoS One. 2017;12:e0174126.
    >> Share

  100. CHANG YW, Singh KP
    Long-term exposure to estrogen enhances chemotherapeutic efficacy potentially through epigenetic mechanism in human breast cancer cells.
    PLoS One. 2017;12:e0174227.
    >> Share

  101. HAN J, Lee HB, Lee ES, Kang YJ, et al
    The treatment outcomes and the use of adjuvant therapies in breast cancer patients with severe co-morbidities.
    PLoS One. 2017;12:e0173721.
    >> Share

  102. ZHANG N, Fielding R, Soong I, Chan KK, et al
    Psychometric assessment of the Chinese version of the brief illness perception questionnaire in breast cancer survivors.
    PLoS One. 2017;12:e0174093.
    >> Share

  103. STANKEVICINS L, Barat A, Dessen P, Vassetzky Y, et al
    The microRNA-205-5p is correlated to metastatic potential of 21T series: A breast cancer progression model.
    PLoS One. 2017;12:e0173756.
    >> Share

  104. GUIMARAES E, Machado R, Fonseca MC, Franca A, et al
    Inositol 1, 4, 5-trisphosphate-dependent nuclear calcium signals regulate angiogenesis and cell motility in triple negative breast cancer.
    PLoS One. 2017;12:e0175041.
    >> Share

  105. ZHAO M, Howard EW, Guo Z, Parris AB, et al
    p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells.
    PLoS One. 2017;12:e0175121.
    >> Share

  106. FANG S, Tian H, Li X, Jin D, et al
    Clinical application of a microfluidic chip for immunocapture and quantification of circulating exosomes to assist breast cancer diagnosis and molecular classification.
    PLoS One. 2017;12:e0175050.
    >> Share

  107. Retraction: Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer Cells.
    PLoS One. 2017;12:e0175772.
    >> Share

  108. Retraction: miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells.
    PLoS One. 2017;12:e0175869.
    >> Share

  109. KIM MS, Kim SY, Kim JH, Park B, et al
    Depression in breast cancer patients who have undergone mastectomy: A national cohort study.
    PLoS One. 2017;12:e0175395.
    >> Share

  110. GUO Y, Yu P, Liu Z, Maimaiti Y, et al
    Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    PLoS One. 2017;12:e0174843.
    >> Share

  111. EL GUERRAB A, Cayre A, Kwiatkowski F, Privat M, et al
    Quantification of hypoxia-related gene expression as a potential approach for clinical outcome prediction in breast cancer.
    PLoS One. 2017;12:e0175960.
    >> Share

  112. TIRAN V, Stanzer S, Heitzer E, Meilinger M, et al
    Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    PLoS One. 2017;12:e0175223.
    >> Share

  113. CASTLE J, Morris K, Pritchard S, Kirwan CC, et al
    Challenges in enumeration of CTCs in breast cancer using techniques independent of cytokeratin expression.
    PLoS One. 2017;12:e0175647.
    >> Share

  114. AHN SG, Lee JH, Lee HW, Jeon TJ, et al
    Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    PLoS One. 2017;12:e0175048.
    >> Share

  115. GRONBERG M, Ahlin C, Naeser Y, Janson ET, et al
    Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer.
    PLoS One. 2017;12:e0176059.
    >> Share

  116. HADJIALIREZAEI S, Picco G, Beatson R, Burchell J, et al
    Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
    PLoS One. 2017;12:e0175323.
    >> Share

  117. BOYD A, Stoodley P, Richards D, Hui R, et al
    Anthracyclines induce early changes in left ventricular systolic and diastolic function: A single centre study.
    PLoS One. 2017;12:e0175544.
    >> Share

  118. MOHD MUJAR NM, Dahlui M, Emran NA, Abdul Hadi I, et al
    Complementary and alternative medicine (CAM) use and delays in presentation and diagnosis of breast cancer patients in public hospitals in Malaysia.
    PLoS One. 2017;12:e0176394.
    >> Share

  119. ALIMOHAMMADI M, Lahiani MH, McGehee D, Khodakovskaya M, et al
    Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells.
    PLoS One. 2017;12:e0175778.
    >> Share

  120. LU T, Gu M, Zhao Y, Zheng X, et al
    Autophagy contributes to falcarindiol-induced cell death in breast cancer cells with enhanced endoplasmic reticulum stress.
    PLoS One. 2017;12:e0176348.
    >> Share

  121. BAUER D, Redmon N, Mazzio E, Soliman KF, et al
    Apigenin inhibits TNFalpha/IL-1alpha-induced CCL2 release through IKBK-epsilon signaling in MDA-MB-231 human breast cancer cells.
    PLoS One. 2017;12:e0175558.
    >> Share

  122. ZHOU W, Song F, Wu Q, Liu R, et al
    miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    PLoS One. 2017;12:e0176395.
    >> Share

  123. CHEN S, Tao J, Zhong F, Jiao Y, et al
    Polydatin down-regulates the phosphorylation level of Creb and induces apoptosis in human breast cancer cell.
    PLoS One. 2017;12:e0176501.
    >> Share

  124. GOODE G, Gunda V, Chaika NV, Purohit V, et al
    MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    PLoS One. 2017;12:e0176820.
    >> Share

  125. BARTEL CA, Jackson MW
    HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss.
    PLoS One. 2017;12:e0176778.
    >> Share

  126. PIO GM, Xia Y, Piaseczny MM, Chu JE, et al
    Soluble bone-derived osteopontin promotes migration and stem-like behavior of breast cancer cells.
    PLoS One. 2017;12:e0177640.
    >> Share

  127. CHANDA A, Chan A, Deng L, Kornaga EN, et al
    Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.
    PLoS One. 2017;12:e0177639.
    >> Share

  128. COLLINS D, Jacob W, Cejalvo JM, Ceppi M, et al
    Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer.
    PLoS One. 2017;12:e0177331.
    >> Share

  129. TAKEUCHI H, Kawanaka H, Fukuyama S, Kubo N, et al
    Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer.
    PLoS One. 2017;12:e0177137.
    >> Share

  130. KANOMATA N, Matsuura S, Nomura T, Kurebayashi J, et al
    Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
    PLoS One. 2017;12:e0177439.
    >> Share

  131. SANTRA T, Roche S, Conlon N, O'Donovan N, et al
    Identification of potential new treatment response markers and therapeutic targets using a Gaussian process-based method in lapatinib insensitive breast cancer models.
    PLoS One. 2017;12:e0177058.
    >> Share

  132. HULTGREN EM, Patrick ME, Evans RL, Stoos CT, et al
    SUSD2 promotes tumor-associated macrophage recruitment by increasing levels of MCP-1 in breast cancer.
    PLoS One. 2017;12:e0177089.
    >> Share

  133. MARTINEZ ME, Unkart JT, Tao L, Kroenke CH, et al
    Prognostic significance of marital status in breast cancer survival: A population-based study.
    PLoS One. 2017;12:e0175515.
    >> Share

  134. MISHRA AK, Parish CR, Wong ML, Licinio J, et al
    Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancer.
    PLoS One. 2017;12:e0178454.
    >> Share

  135. EVERS C, Fischer C, Dikow N, Schott S, et al
    Familial breast cancer: Genetic counseling over time, including patients expectations and initiators considering the Angelina Jolie effect.
    PLoS One. 2017;12:e0177893.
    >> Share

  136. CHOI Y, Kim SH, Youn IK, Kang BJ, et al
    Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype.
    PLoS One. 2017;12:e0177903.
    >> Share

  137. LIU Z, He K, Ma Q, Yu Q, et al
    Autophagy inhibitor facilitates gefitinib sensitivity in vitro and in vivo by activating mitochondrial apoptosis in triple negative breast cancer.
    PLoS One. 2017;12:e0177694.
    >> Share

  138. SCHMITZ AMT, Teixeira SC, Pengel KE, Loo CE, et al
    Monitoring tumor response to neoadjuvant chemotherapy using MRI and 18F-FDG PET/CT in breast cancer subtypes.
    PLoS One. 2017;12:e0176782.
    >> Share

  139. WANG XY, Hu Q, Fang MY, He Y, et al
    The correlation between HER-2 expression and the CEUS and ARFI characteristics of breast cancer.
    PLoS One. 2017;12:e0178692.
    >> Share

  140. GOODE G, Gunda V, Chaika NV, Purohit V, et al
    Correction: MUC1 facilitates metabolomic reprogramming in triple-negative breast cancer.
    PLoS One. 2017;12:e0179098.
    >> Share

  141. ARAUJO T, Aresta G, Castro E, Rouco J, et al
    Classification of breast cancer histology images using Convolutional Neural Networks.
    PLoS One. 2017;12:e0177544.
    >> Share

  142. GWEON HM, Jeong J, Son EJ, Youk JH, et al
    The clinical significance of accompanying NME on preoperative MR imaging in breast cancer patients.
    PLoS One. 2017;12:e0178445.
    >> Share

  143. DE GROEF A, Van Kampen M, Vervloesem N, De Geyter S, et al
    An evaluation tool for myofascial adhesions in patients after breast cancer (MAP-BC evaluation tool): Development and interrater reliability.
    PLoS One. 2017;12:e0179116.
    >> Share

  144. GAMEZ-POZO A, Trilla-Fuertes L, Prado-Vazquez G, Chiva C, et al
    Prediction of adjuvant chemotherapy response in triple negative breast cancer with discovery and targeted proteomics.
    PLoS One. 2017;12:e0178296.
    >> Share

  145. ZHU RM, Lin W, Zhang W, Ren JT, et al
    Modification effects of genetic polymorphisms in FTO, IL-6, and HSPD1 on the associations of diabetes with breast cancer risk and survival.
    PLoS One. 2017;12:e0178850.
    >> Share

  146. JAEGER BAS, Neugebauer J, Andergassen U, Melcher C, et al
    The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial.
    PLoS One. 2017;12:e0173593.
    >> Share

  147. BORIN TF, Shankar A, Angara K, Rashid MH, et al
    HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.
    PLoS One. 2017;12:e0178830.
    >> Share

  148. TSAI YF, Tseng LM, Hsu CY, Yang MH, et al
    Brain-derived neurotrophic factor (BDNF) -TrKB signaling modulates cancer-endothelial cells interaction and affects the outcomes of triple negative breast cancer.
    PLoS One. 2017;12:e0178173.
    >> Share

  149. KIM HS, Tian L, Kim H, Moon WK, et al
    Investigation of discriminant metabolites in tamoxifen-resistant and choline kinase-alpha-downregulated breast cancer cells using 1H-nuclear magnetic resonance spectroscopy.
    PLoS One. 2017;12:e0179773.
    >> Share

  150. NAZIROGLU M, Cig B, Blum W, Vizler C, et al
    Targeting breast cancer cells by MRS1477, a positive allosteric modulator of TRPV1 channels.
    PLoS One. 2017;12:e0179950.
    >> Share

  151. BUEHRING GC, Shen H, Schwartz DA, Lawson JS, et al
    Bovine leukemia virus linked to breast cancer in Australian women and identified before breast cancer development.
    PLoS One. 2017;12:e0179367.
    >> Share

  152. LIU JC, Zacksenhouse M, Eisen A, Nofech-Mozes S, et al
    Identification of cell proliferation, immune response and cell migration as critical pathways in a prognostic signature for HER2+:ERalpha- breast cancer.
    PLoS One. 2017;12:e0179223.
    >> Share

  153. BJORGE JD, Pang A, Fujita DJ
    Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release.
    PLoS One. 2017;12:e0180578.
    >> Share

  154. TAMURA M, Sugiura S, Takagi T, Satoh T, et al
    Morphology-based optical separation of subpopulations from a heterogeneous murine breast cancer cell line.
    PLoS One. 2017;12:e0179372.
    >> Share

  155. JEONG J, Park S, An HT, Kang M, et al
    Small leucine zipper protein functions as a negative regulator of estrogen receptor alpha in breast cancer.
    PLoS One. 2017;12:e0180197.
    >> Share

  156. AMARA S, Majors C, Roy B, Hill S, et al
    Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation.
    PLoS One. 2017;12:e0180097.
    >> Share

  157. SKOOG P, Ohlsson M, Ferno M, Ryden L, et al
    Tumor tissue protein signatures reflect histological grade of breast cancer.
    PLoS One. 2017;12:e0179775.
    >> Share

  158. JI W, Wang B, Fan Q, Xu C, et al
    Chemosensitizing indomethacin-conjugated dextran-based micelles for effective delivery of paclitaxel in resistant breast cancer therapy.
    PLoS One. 2017;12:e0180037.
    >> Share

  159. CAO H, Li C, Qi W, Meng X, et al
    Synthesis, cytotoxicity and antitumour mechanism investigations of polyoxometalate doped silica nanospheres on breast cancer MCF-7 cells.
    PLoS One. 2017;12:e0181018.
    >> Share

  160. BALHOUSE BN, Patterson L, Schmelz EM, Slade DJ, et al
    N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro.
    PLoS One. 2017;12:e0180372.
    >> Share

  161. PASCUAL T, Apellaniz-Ruiz M, Pernaut C, Cueto-Felgueroso C, et al
    Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer.
    PLoS One. 2017;12:e0180192.
    >> Share

  162. KONG W, Mou X, Deng J, Di B, et al
    Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
    PLoS One. 2017;12:e0180337.
    >> Share

  163. ABANA CO, Bingham BS, Cho JH, Graves AJ, et al
    IL-6 variant is associated with metastasis in breast cancer patients.
    PLoS One. 2017;12:e0181725.
    >> Share

  164. DONNELLY TT, Al-Khater AH, Al-Bader SB, Al-Kuwari MG, et al
    Perceptions of Arab men regarding female breast cancer screening examinations-Findings from a Middle East study.
    PLoS One. 2017;12:e0180696.
    >> Share

  165. SADIGHI S, Zokaasadi M, Kasaeian A, Maghsudi S, et al
    The effect of immunohistochemically detected p53 accumulation in prognosis of breast cancer; A retrospective survey of outcome.
    PLoS One. 2017;12:e0182444.
    >> Share

  166. ETTI IC, Abdullah R, Kadir A, Hashim NM, et al
    The molecular mechanism of the anticancer effect of Artonin E in MDA-MB 231 triple negative breast cancer cells.
    PLoS One. 2017;12:e0182357.
    >> Share

  167. SIM SH, Bae CD, Kwon Y, Hwang HL, et al
    CKAP2 (cytoskeleton-associated protein2) is a new prognostic marker in HER2-negative luminal type breast cancer.
    PLoS One. 2017;12:e0182107.
    >> Share

  168. MATOSSIAN MD, Elliott S, Hoang VT, Burks HE, et al
    Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
    PLoS One. 2017;12:e0177802.
    >> Share

  169. CUBASCH H, Joffe M, Ruff P, Dietz D, et al
    Breast conservation surgery versus total mastectomy among women with localized breast cancer in Soweto, South Africa.
    PLoS One. 2017;12:e0182125.
    >> Share

  170. ZAGOURI F, Kotoula V, Kouvatseas G, Sotiropoulou M, et al
    Protein expression patterns of cell cycle regulators in operable breast cancer.
    PLoS One. 2017;12:e0180489.
    >> Share

  171. LEE S, Jiang X
    Modeling miRNA-mRNA interactions that cause phenotypic abnormality in breast cancer patients.
    PLoS One. 2017;12:e0182666.
    >> Share

  172. KANOMATA N, Matsuura S, Nomura T, Kurebayashi J, et al
    Correction: Preparation of a novel antiserum to aromatase with high affinity and specificity: Its clinicopathological significance on breast cancer tissue.
    PLoS One. 2017;12:e0183202.
    >> Share

  173. WANG RC, Chen X, Parissenti AM, Joy AA, et al
    Sensitivity of docetaxel-resistant MCF-7 breast cancer cells to microtubule-destabilizing agents including vinca alkaloids and colchicine-site binding agents.
    PLoS One. 2017;12:e0182400.
    >> Share

  174. PARK IA, Hwang SH, Song IH, Heo SH, et al
    Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
    PLoS One. 2017;12:e0182786.
    >> Share

  175. LI M, Chen K, Liu F, Su F, et al
    Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database.
    PLoS One. 2017;12:e0183448.
    >> Share

  176. HOSOKAWA Y, Masaki N, Takei S, Horikawa M, et al
    Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues.
    PLoS One. 2017;12:e0183724.
    >> Share

  177. YTTERSIAN SLETTA K, Tveitaras MK, Lu N, Engelsen AST, et al
    Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts.
    PLoS One. 2017;12:e0183254.
    >> Share

  178. WANG J, Kong X, Xing Z, Wang X, et al
    A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?
    PLoS One. 2017;12:e0183012.
    >> Share

  179. CHIEN TJ, Hsu CH, Liu CY, Fang CJ, et al
    Effect of acupuncture on hot flush and menopause symptoms in breast cancer- A systematic review and meta-analysis.
    PLoS One. 2017;12:e0180918.
    >> Share

  180. MA S, Dielschneider RF, Henson ES, Xiao W, et al
    Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells.
    PLoS One. 2017;12:e0182921.
    >> Share

  181. CASTELLANO I, Metovic J, Balmativola D, Annaratone L, et al
    The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.
    PLoS One. 2017;12:e0182073.
    >> Share

  182. TANG C, Wang P, Li X, Zhao B, et al
    Lymph node status have a prognostic impact in breast cancer patients with distant metastasis.
    PLoS One. 2017;12:e0182953.
    >> Share

  183. MAHMOUD AM, Macias V, Al-Alem U, Deaton RJ, et al
    BRCA1 protein expression and subcellular localization in primary breast cancer: Automated digital microscopy analysis of tissue microarrays.
    PLoS One. 2017;12:e0184385.
    >> Share

  184. BOSL A, Spitzmuller A, Jasarevic Z, Rauch S, et al
    MammaPrint versus EndoPredict: Poor correlation in disease recurrence risk classification of hormone receptor positive breast cancer.
    PLoS One. 2017;12:e0183458.
    >> Share

  185. HANNA M, Dumas I, Orain M, Jacob S, et al
    Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients.
    PLoS One. 2017;12:e0183579.
    >> Share

  186. WEN Y, Chen Z, Lu J, Ables E, et al
    Quantitative analysis and comparison of 3D morphology between viable and apoptotic MCF-7 breast cancer cells and characterization of nuclear fragmentation.
    PLoS One. 2017;12:e0184726.
    >> Share

  187. SCHULTZ DJ, Muluhngwi P, Alizadeh-Rad N, Green MA, et al
    Genome-wide miRNA response to anacardic acid in breast cancer cells.
    PLoS One. 2017;12:e0184471.
    >> Share

  188. CHENG SH, Huang TT, Cheng YH, Tan TBK, et al
    Validation of the 18-gene classifier as a prognostic biomarker of distant metastasis in breast cancer.
    PLoS One. 2017;12:e0184372.
    >> Share

  189. PELAEZ-GARCIA A, Yebenes L, Berjon A, Angulo A, et al
    Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
    PLoS One. 2017;12:e0183452.
    >> Share

  190. CHANDLER MR, Keene KS, Tuomela JM, Forero-Torres A, et al
    Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
    PLoS One. 2017;12:e0183832.
    >> Share

  191. KWIECIEN JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, et al
    Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis.
    PLoS One. 2017;12:e0183883.
    >> Share

  192. ETTL J, Klein E, Hapfelmeier A, Grosse Lackmann K, et al
    Decision impact and feasibility of different ASCO-recommended biomarkers in early breast cancer: Prospective comparison of molecular marker EndoPredict and protein marker uPA/PAI-1.
    PLoS One. 2017;12:e0183917.
    >> Share

  193. SU S, Bao H, Wang X, Wang Z, et al
    The quality of invasive breast cancer care for low reimbursement rate patients: A retrospective study.
    PLoS One. 2017;12:e0184866.
    >> Share

  194. ZEIDAN AM, Long JB, Wang R, Hu X, et al
    Risk of myeloid neoplasms after radiotherapy among older women with localized breast cancer: A population-based study.
    PLoS One. 2017;12:e0184747.
    >> Share

  195. LEFTIN A, Ben-Chetrit N, Klemm F, Joyce JA, et al
    Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer.
    PLoS One. 2017;12:e0184765.
    >> Share

  196. FUKADA I, Ito Y, Kobayashi K, Shibayama T, et al
    The early onset of peripheral neuropathy might be a robust predictor for time to treatment failure in patients with metastatic breast cancer receiving chemotherapy containing paclitaxel.
    PLoS One. 2017;12:e0184322.
    >> Share

  197. LU S, Qian Y, Huang X, Yu H, et al
    The association of dietary pattern and breast cancer in Jiangsu, China: A population-based case-control study.
    PLoS One. 2017;12:e0184453.
    >> Share

  198. POPOLIN CP, Reis JPB, Becceneri AB, Graminha AE, et al
    Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells.
    PLoS One. 2017;12:e0183275.
    >> Share

  199. GOTZ TI, Lahmer G, Strnad V, Bert C, et al
    A tool to automatically analyze electromagnetic tracking data from high dose rate brachytherapy of breast cancer patients.
    PLoS One. 2017;12:e0183608.
    >> Share

  200. PARK NJ, Chang Y, Bender C, Conley Y, et al
    Cardiovascular disease and mortality after breast cancer in postmenopausal women: Results from the Women's Health Initiative.
    PLoS One. 2017;12:e0184174.
    >> Share

  201. BUONOMO OC, Caredda E, Portarena I, Vanni G, et al
    New insights into the metastatic behavior after breast cancer surgery, according to well-established clinicopathological variables and molecular subtypes.
    PLoS One. 2017;12:e0184680.
    >> Share

  202. PADALA C, Tupurani MA, Puranam K, Gantala S, et al
    Synergistic effect of collagenase-1 (MMP1), stromelysin-1 (MMP3) and gelatinase-B (MMP9) gene polymorphisms in breast cancer.
    PLoS One. 2017;12:e0184448.
    >> Share

  203. FUJII T, Reuben JM, Huo L, Espinosa Fernandez JR, et al
    Androgen receptor expression on circulating tumor cells in metastatic breast cancer.
    PLoS One. 2017;12:e0185231.
    >> Share

  204. LAMPA M, Arlt H, He T, Ospina B, et al
    Glutaminase is essential for the growth of triple-negative breast cancer cells with a deregulated glutamine metabolism pathway and its suppression synergizes with mTOR inhibition.
    PLoS One. 2017;12:e0185092.
    >> Share

  205. SCHMITZ AMT, Veldhuis WB, Menke-Pluijmers MBE, van der Kemp WJM, et al
    Preoperative indication for systemic therapy extended to patients with early-stage breast cancer using multiparametric 7-tesla breast MRI.
    PLoS One. 2017;12:e0183855.
    >> Share

  206. GSCHWANTLER-KAULICH D, Weingartshofer S, Grunt TW, Mairhofer M, et al
    Estradiol impairs the antiproliferative and proapoptotic effect of Zoledronic acid in hormone sensitive breast cancer cells in vitro.
    PLoS One. 2017;12:e0185566.
    >> Share

  207. SUCHANSKI J, Tejchman A, Zacharski M, Piotrowska A, et al
    Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    PLoS One. 2017;12:e0184970.
    >> Share

  208. ZHANG W, Wang W, Chai W, Luo X, et al
    Breast tissue ablation with irreversible electroporation in rabbits: A safety and feasibility study.
    PLoS One. 2017;12:e0181555.
    >> Share

  209. DI NAPOLI A, Pepe G, Giarnieri E, Cippitelli C, et al
    Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    PLoS One. 2017;12:e0181097.
    >> Share

  210. SANO H, Goto R, Hamashima C
    Does lack of resources impair access to breast and cervical cancer screening in Japan?
    PLoS One. 2017;12:e0180819.
    >> Share

  211. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    >> Share

  212. MARQUEZ-RODAS I, Pollan M, Escudero MJ, Ruiz A, et al
    Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "El Alamo III" retrospective study.
    PLoS One. 2017;12:e0184181.
    >> Share

  213. CILEK EE, Ozturk H, Gur Dedeoglu B
    Construction of miRNA-miRNA networks revealing the complexity of miRNA-mediated mechanisms in trastuzumab treated breast cancer cell lines.
    PLoS One. 2017;12:e0185558.
    >> Share

  214. AUKES K, Forsman C, Brady NJ, Astleford K, et al
    Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions.
    PLoS One. 2017;12:e0185736.
    >> Share

  215. KORKOLA JE, Collisson EA, Heiser LM, Oates C, et al
    Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer.
    PLoS One. 2017;12:e0186551.
    >> Share

  216. QIAO W, Jia Z, Liu H, Liu Q, et al
    Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
    PLoS One. 2017;12:e0186191.
    >> Share

  217. XIE F, Hosany S, Zhong S, Jiang Y, et al
    MicroRNA-193a inhibits breast cancer proliferation and metastasis by downregulating WT1.
    PLoS One. 2017;12:e0185565.
    >> Share

  218. THIRUNAVUKKARASAN M, Wang C, Rao A, Hind T, et al
    Short-chain fatty acid receptors inhibit invasive phenotypes in breast cancer cells.
    PLoS One. 2017;12:e0186334.
    >> Share

  219. MAHAJAN AS, Sugita BM, Duttargi AN, Saenz F, et al
    Genomic comparison of early-passage conditionally reprogrammed breast cancer cells to their corresponding primary tumors.
    PLoS One. 2017;12:e0186190.
    >> Share

  220. RAZAZAN A, Behravan J, Arab A, Barati N, et al
    Conjugated nanoliposome with the HER2/neu-derived peptide GP2 as an effective vaccine against breast cancer in mice xenograft model.
    PLoS One. 2017;12:e0185099.
    >> Share

  221. HEQUET D, Callens C, Gentien D, Albaud B, et al
    Prospective, multicenter French study evaluating the clinical impact of the Breast Cancer Intrinsic Subtype-Prosigna(R) Test in the management of early-stage breast cancers.
    PLoS One. 2017;12:e0185753.
    >> Share

  222. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    >> Share

  223. VALIANATOS G, Valcikova B, Growkova K, Verlande A, et al
    A small molecule drug promoting miRNA processing induces alternative splicing of MdmX transcript and rescues p53 activity in human cancer cells overexpressing MdmX protein.
    PLoS One. 2017;12:e0185801.
    >> Share

  224. HEBBRECHT T, Van Audenhove I, Zwaenepoel O, Verhelle A, et al
    VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    PLoS One. 2017;12:e0185076.
    >> Share

  225. NISHIMUKAI A, Inoue N, Kira A, Takeda M, et al
    Tumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
    PLoS One. 2017;12:e0184508.
    >> Share

  226. SERRANO-GOMEZ SJ, Sanabria-Salas MC, Garay J, Baddoo MC, et al
    Ancestry as a potential modifier of gene expression in breast tumors from Colombian women.
    PLoS One. 2017;12:e0183179.
    >> Share

  227. DIMITROPOULOS K, Barmpoutis P, Zioga C, Kamas A, et al
    Grading of invasive breast carcinoma through Grassmannian VLAD encoding.
    PLoS One. 2017;12:e0185110.
    >> Share

  228. KANG HJ, Kim SW, Son SH
    The feasibility of a heart block with an electron compensation as an alternative whole breast radiotherapy technique in patients with underlying cardiac or pulmonary disease.
    PLoS One. 2017;12:e0184137.
    >> Share

  229. CHEN Z, Yang J, Li S, Lv M, et al
    Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
    PLoS One. 2017;12:e0182397.
    >> Share

  230. PARK JM, Bae SJ, Yoon C, Lee HS, et al
    Comparison of patients with small (</=2 cm) breast cancer according to adherence to breast screening program.
    PLoS One. 2017;12:e0186988.
    >> Share

  231. LAI HW, Liu LC, Ouyang F, Yao CC, et al
    Multi-center study on patient selection for and the oncologic safety of intraoperative radiotherapy (IORT) with the Xoft Axxent(R) eBx(R) System for the management of early stage breast cancer in Taiwan.
    PLoS One. 2017;12:e0185876.
    >> Share

  232. HENLE AM, Nassar A, Puglisi-Knutson D, Youssef B, et al
    Downregulation of TAP1 and TAP2 in early stage breast cancer.
    PLoS One. 2017;12:e0187323.
    >> Share

  233. COIGNET MV, Zirpoli GR, Roberts MR, Khoury T, et al
    Genetic variations, reproductive aging, and breast cancer risk in African American and European American women: The Women's Circle of Health Study.
    PLoS One. 2017;12:e0187205.
    >> Share

  234. JOHANNESSEN C, Moi L, Kiselev Y, Pedersen MI, et al
    Expression and function of the miR-143/145 cluster in vitro and in vivo in human breast cancer.
    PLoS One. 2017;12:e0186658.
    >> Share

  235. REESE DE, Henderson MC, Silver M, Mulpuri R, et al
    Breast density does not impact the ability of Videssa(R) Breast to detect breast cancer in women under age 50.
    PLoS One. 2017;12:e0186198.
    >> Share

  236. SUNG PL, Wen KC, Chen YJ, Chao TC, et al
    The frequency of cancer predisposition gene mutations in hereditary breast and ovarian cancer patients in Taiwan: From BRCA1/2 to multi-gene panels.
    PLoS One. 2017;12:e0185615.
    >> Share

  237. LAROCHE F, Perrot S, Medkour T, Cottu PH, et al
    Quality of life and impact of pain in women treated with aromatase inhibitors for breast cancer. A multicenter cohort study.
    PLoS One. 2017;12:e0187165.
    >> Share

  238. WAKAI R, Ishitsuka M, Kishimoto T, Ochiai T, et al
    Identification of genes and critical control proteins associated with inflammatory breast cancer using network controllability.
    PLoS One. 2017;12:e0186353.
    >> Share

  239. THERIAU CF, Sauve OS, Beaudoin MS, Wright DC, et al
    Proliferative endocrine effects of adipose tissue from obese animals on MCF7 cells are ameliorated by resveratrol supplementation.
    PLoS One. 2017;12:e0183897.
    >> Share

  240. HIRONAKA-MITSUHASHI A, Matsuzaki J, Takahashi RU, Yoshida M, et al
    A tissue microRNA signature that predicts the prognosis of breast cancer in young women.
    PLoS One. 2017;12:e0187638.
    >> Share

  241. SYED S, Schober J, Blanco A, Zustiak SP, et al
    Morphological adaptations in breast cancer cells as a function of prolonged passaging on compliant substrates.
    PLoS One. 2017;12:e0187853.
    >> Share

  242. CARLSEN JF, Ewertsen C, Sletting S, Talman ML, et al
    Strain histograms are equal to strain ratios in predicting malignancy in breast tumours.
    PLoS One. 2017;12:e0186230.
    >> Share

  243. KYEONG S, Cha YJ, Ahn SG, Suh SH, et al
    Subtypes of breast cancer show different spatial distributions of brain metastases.
    PLoS One. 2017;12:e0188542.
    >> Share

  244. THOMPSON KJ, Ingle JN, Tang X, Chia N, et al
    A comprehensive analysis of breast cancer microbiota and host gene expression.
    PLoS One. 2017;12:e0188873.
    >> Share

  245. MARINHO EDC, Custodio IDD, Ferreira IB, Crispim CA, et al
    Impact of chemotherapy on perceptions related to food intake in women with breast cancer: A prospective study.
    PLoS One. 2017;12:e0187573.
    >> Share

  246. AZIZI M, Ghourchian H, Yazdian F, Dashtestani F, et al
    Cytotoxic effect of albumin coated copper nanoparticle on human breast cancer cells of MDA-MB 231.
    PLoS One. 2017;12:e0188639.
    >> Share

  247. MAYORAL-VARO V, Calcabrini A, Sanchez-Bailon MP, Martin-Perez J, et al
    miR205 inhibits stem cell renewal in SUM159PT breast cancer cells.
    PLoS One. 2017;12:e0188637.
    >> Share

  248. ARENAS M, Garcia-Heredia A, Cabre N, Luciano-Mateo F, et al
    Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients.
    PLoS One. 2017;12:e0188633.
    >> Share

  249. AHN SG, Bae SJ, Yoon C, Cha YJ, et al
    Chemosensitivity to doxorubicin of ER-positive/HER2-negative breast cancers with high 21-gene recurrence score: A study based on in vitro chemoresponse assay.
    PLoS One. 2017;12:e0187679.
    >> Share

  250. ZEUNE L, van Dalum G, Decraene C, Proudhon C, et al
    Quantifying HER-2 expression on circulating tumor cells by ACCEPT.
    PLoS One. 2017;12:e0186562.
    >> Share

  251. TAKEUCHI H, Abe M, Takumi Y, Hashimoto T, et al
    The prognostic impact of the platelet distribution width-to-platelet count ratio in patients with breast cancer.
    PLoS One. 2017;12:e0189166.
    >> Share

  252. KASANGIAN AA, Gherardi G, Biagioli E, Torri V, et al
    The prognostic role of tumor size in early breast cancer in the era of molecular biology.
    PLoS One. 2017;12:e0189127.
    >> Share

  253. AGARWAL S, Ying J, Boucher KM, Agarwal JP, et al
    The association between socioeconomic factors and breast cancer-specific survival varies by race.
    PLoS One. 2017;12:e0187018.
    >> Share

  254. DAVIES G, Lobanova L, Dawicki W, Groot G, et al
    Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
    PLoS One. 2017;12:e0187191.
    >> Share

  255. ZHANG H, Diao H, Jia L, Yuan Y, et al
    Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model.
    PLoS One. 2017;12:e0188960.
    >> Share

  256. ALEMAR B, Gregorio C, Herzog J, Matzenbacher Bittar C, et al
    BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
    PLoS One. 2017;12:e0187630.
    >> Share

  257. KIM GE, Lee JS, Park MH, Yoon JH, et al
    Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
    PLoS One. 2017;12:e0187635.
    >> Share

  258. HENDERSON HJ, Karanam B, Samant R, Vig K, et al
    Neuroligin 4X overexpression in human breast cancer is associated with poor relapse-free survival.
    PLoS One. 2017;12:e0189662.
    >> Share

  259. ZEINOMAR N, Thai A, Cloud AJ, McDonald JA, et al
    Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family Registry.
    PLoS One. 2017;12:e0189118.
    >> Share

  260. SYED BM, Morgan D, Setty T, Green AR, et al
    Oestrogen receptor negative early operable primary breast cancer in older women-Biological characteristics and long-term clinical outcome.
    PLoS One. 2017;12:e0188528.
    >> Share

  261. FATIMA I, El-Ayachi I, Taotao L, Lillo MA, et al
    The natural compound Jatrophone interferes with Wnt/beta-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.
    PLoS One. 2017;12:e0189864.
    >> Share

  262. SOBRAL-LEITE M, Lips EH, Vieira-Monteiro HA, Giacomin LC, et al
    Evaluation of the EGFR polymorphism R497K in two cohorts of neoadjuvantly treated breast cancer patients.
    PLoS One. 2017;12:e0189750.
    >> Share

  263. DABI Y, Darrigues L, Pons K, Mabille M, et al
    Incidence of inflammatory breast cancer in patients with clinical inflammatory breast symptoms.
    PLoS One. 2017;12:e0189385.
    >> Share

  264. LIU CY, Lau KY, Hsu CC, Chen JL, et al
    Combination of palbociclib with enzalutamide shows in vitro activity in RB proficient and androgen receptor positive triple negative breast cancer cells.
    PLoS One. 2017;12:e0189007.
    >> Share

  265. RUMNEY RMH, Coffelt SB, Neale TA, Dhayade S, et al
    PyMT-Maclow: A novel, inducible, murine model for determining the role of CD68 positive cells in breast tumor development.
    PLoS One. 2017;12:e0188591.
    >> Share

  266. FIOCCHETTI M, Cipolletti M, Marino M
    Compensatory role of Neuroglobin in nervous and non-nervous cancer cells in response to the nutrient deprivation.
    PLoS One. 2017;12:e0189179.
    >> Share

  267. CATTANEO ER, Prieto ED, Garcia-Fabiani MB, Montanaro MA, et al
    Glycerol-3-phosphate acyltransferase 2 expression modulates cell roughness and membrane permeability: An atomic force microscopy study.
    PLoS One. 2017;12:e0189031.
    >> Share

  268. CARNESECCHI J, Cerutti C, Vanacker JM, Forcet C, et al
    ERRalpha protein is stabilized by LSD1 in a demethylation-independent manner.
    PLoS One. 2017;12:e0188871.
    >> Share

  269. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI for the assessment of malignancy in BI-RADS 4 mammographic microcalcifications.
    PLoS One. 2017;12:e0188679.
    >> Share

  270. DENIZ S, Kurt B, Oguzoncul AF, Nazlican E, et al
    Knowledge, attitudes and behaviours of women regarding breast and cervical cancer in Malatya, Turkey.
    PLoS One. 2017;12:e0188571.
    >> Share

  271. ORTIZ AB, Garcia D, Vicente Y, Palka M, et al
    Prognostic significance of cyclin D1 protein expression and gene amplification in invasive breast carcinoma.
    PLoS One. 2017;12:e0188068.
    >> Share

  272. JIN D, Lee H
    FGMD: A novel approach for functional gene module detection in cancer.
    PLoS One. 2017;12:e0188900.
    >> Share

  273. PAUL B, Royston KJ, Li Y, Stoll ML, et al
    Impact of genistein on the gut microbiome of humanized mice and its role in breast tumor inhibition.
    PLoS One. 2017;12:e0189756.
    >> Share

  274. HANLEY JA, Hannigan A, O'Brien KM
    Mortality reductions due to mammography screening: Contemporary population-based data.
    PLoS One. 2017;12:e0188947.
    >> Share

    January 2016
  275. BALAJI SA, Udupa N, Chamallamudi MR, Gupta V, et al
    Role of the Drug Transporter ABCC3 in Breast Cancer Chemoresistance.
    PLoS One. 2016;11:e0155013.
    >> Share

  276. APRELIKOVA O, Tomlinson CC, Hoenerhoff M, Hixon JA, et al
    Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases.
    PLoS One. 2016;11:e0155262.
    >> Share

  277. KALA R, Tollefsbol TO
    A Novel Combinatorial Epigenetic Therapy Using Resveratrol and Pterostilbene for Restoring Estrogen Receptor-alpha (ERalpha) Expression in ERalpha-Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0155057.
    >> Share

  278. YANG J, Niu H, Huang Y, Yang K, et al
    A Systematic Analysis of the Relationship of CDH13 Promoter Methylation and Breast Cancer Risk and Prognosis.
    PLoS One. 2016;11:e0149185.
    >> Share

  279. BASTOS EP, Brentani H, Pereira CA, Polpo A, et al
    A Set of miRNAs, Their Gene and Protein Targets and Stromal Genes Distinguish Early from Late Onset ER Positive Breast Cancer.
    PLoS One. 2016;11:e0154325.
    >> Share

  280. WON HS, Lee KM, Oh JE, Nam EM, et al
    Inhibition of beta-Catenin to Overcome Endocrine Resistance in Tamoxifen-Resistant Breast Cancer Cell Line.
    PLoS One. 2016;11:e0155983.
    >> Share

  281. LEI L, Yu X, Chen B, Chen Z, et al
    Clinicopathological Characteristics of Mucinous Breast Cancer: A Retrospective Analysis of a 10-Year Study.
    PLoS One. 2016;11:e0155132.
    >> Share

  282. HIGUCHI T, Endo M, Hanamura T, Gohno T, et al
    Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer.
    PLoS One. 2016;11:e0155844.
    >> Share

  283. GUO Y, Yu P, Liu Z, Maimaiti Y, et al
    Prognostic and Clinicopathological Value of Programmed Death Ligand-1 in Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0156323.
    >> Share

  284. GORI S, Inno A, Rossi V, Turazza M, et al
    Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study.
    PLoS One. 2016;11:e0156221.
    >> Share

  285. SOPRANO M, Sorriento D, Rusciano MR, Maione AS, et al
    Oxidative Stress Mediates the Antiproliferative Effects of Nelfinavir in Breast Cancer Cells.
    PLoS One. 2016;11:e0155970.
    >> Share

  286. ZHANG X, Li Y, Zhou Y, Mao F, et al
    Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0155597.
    >> Share

  287. CHEREAU E, Uzan C, Boutmy-Deslandes E, Zohar S, et al
    Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.
    PLoS One. 2016;11:e0156096.
    >> Share

  288. RENAULT AL, Lesueur F, Coulombe Y, Gobeil S, et al
    ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry.
    PLoS One. 2016;11:e0156820.
    >> Share

  289. ZHONG X, Dong Z, Dong H, Li J, et al
    Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
    PLoS One. 2016;11:e0156789.
    >> Share

  290. LEHMANN BD, Jovanovic B, Chen X, Estrada MV, et al
    Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection.
    PLoS One. 2016;11:e0157368.
    >> Share

  291. CUSTODIO ID, Marinho ED, Gontijo CA, Pereira TS, et al
    Impact of Chemotherapy on Diet and Nutritional Status of Women with Breast Cancer: A Prospective Study.
    PLoS One. 2016;11:e0157113.
    >> Share

  292. GUEST SK, Ribas R, Pancholi S, Nikitorowicz-Buniak J, et al
    Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
    PLoS One. 2016;11:e0157397.
    >> Share

  293. ROBERTS GC, Morris PG, Moss MA, Maltby SL, et al
    An Evaluation of Matrix-Containing and Humanised Matrix-Free 3-Dimensional Cell Culture Systems for Studying Breast Cancer.
    PLoS One. 2016;11:e0157004.
    >> Share

  294. LI Y, Wu Q, Li C, Liu L, et al
    Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    PLoS One. 2016;11:e0157576.
    >> Share

  295. LI J, Liu Y, Jiang Y, Shao Z, et al
    Breast Cancer-Specific Mortality Pattern and Its Changing Feature According to Estrogen Receptor Status in Two Time Periods.
    PLoS One. 2016;11:e0157322.
    >> Share

  296. WULANINGSIH W, Holmberg L, Abeler-Doner L, Ng T, et al
    Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    PLoS One. 2016;11:e0157482.
    >> Share

  297. RIVERA RIVERA A, Castillo-Pichardo L, Gerena Y, Dharmawardhane S, et al
    Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
    PLoS One. 2016;11:e0157251.
    >> Share

  298. ZHOU Y, Wang C, Zhu H, Lin Y, et al
    Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.
    PLoS One. 2016;11:e0158143.
    >> Share

  299. TANG Z, Wang J, Zhang H, Sun L, et al
    Associations between Diabetes and Quality of Life among Breast Cancer Survivors.
    PLoS One. 2016;11:e0157791.
    >> Share

  300. VALLEGA KA, Liu N, Myers JS, Yu K, et al
    Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.
    PLoS One. 2016;11:e0157741.
    >> Share

  301. PAEZ-RIBES M, Man S, Xu P, Kerbel RS, et al
    Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
    PLoS One. 2016;11:e0158034.
    >> Share

  302. ZIEGLER YS, Moresco JJ, Yates JR 3rd, Nardulli AM, et al
    Integration of Breast Cancer Secretomes with Clinical Data Elucidates Potential Serum Markers for Disease Detection, Diagnosis, and Prognosis.
    PLoS One. 2016;11:e0158296.
    >> Share

  303. MEDINA-AGUILAR R, Perez-Plasencia C, Marchat LA, Gariglio P, et al
    Methylation Landscape of Human Breast Cancer Cells in Response to Dietary Compound Resveratrol.
    PLoS One. 2016;11:e0157866.
    >> Share

  304. DORLING L, Kar S, Michailidou K, Hiller L, et al
    The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control Study.
    PLoS One. 2016;11:e0158984.
    >> Share

  305. DIAS JA, Fredrikson GN, Ericson U, Gullberg B, et al
    Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmo Diet and Cancer Cohort.
    PLoS One. 2016;11:e0158959.
    >> Share

  306. KOO HY, Seo YG, Cho MH, Kim MJ, et al
    Weight Change and Associated Factors in Long-Term Breast Cancer Survivors.
    PLoS One. 2016;11:e0159098.
    >> Share

  307. HU K, Lou L, Tian W, Pan T, et al
    The Outcome of Breast Cancer Is Associated with National Human Development Index and Health System Attainment.
    PLoS One. 2016;11:e0158951.
    >> Share

  308. SINGH B, Kinne HE, Milligan RD, Washburn LJ, et al
    Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge.
    PLoS One. 2016;11:e0159072.
    >> Share

  309. VALLERAND D, Massonnet G, Kebir F, Gentien D, et al
    Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
    PLoS One. 2016;11:e0157670.
    >> Share

  310. BONSANG-KITZIS H, Chaltier L, Belin L, Savignoni A, et al
    Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.
    PLoS One. 2016;11:e0159123.
    >> Share

  311. CHOI HY, Ko ES, Han BK, Kim EJ, et al
    Prognostic Significance of Transverse Relaxation Rate (R2*) in Blood Oxygenation Level-Dependent Magnetic Resonance Imaging in Patients with Invasive Breast Cancer.
    PLoS One. 2016;11:e0158500.
    >> Share

  312. BENNANI-BAITI B, Dietzel M, Baltzer PA
    MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    PLoS One. 2016;11:e0158573.
    >> Share

  313. CARRIER M, Joint M, Lutzing R, Page A, et al
    Phosphoproteome and Transcriptome of RA-Responsive and RA-Resistant Breast Cancer Cell Lines.
    PLoS One. 2016;11:e0157290.
    >> Share

  314. CHAE EY, Moon WK, Kim HH, Kim WH, et al
    Association between Ultrasound Features and the 21-Gene Recurrence Score Assays in Patients with Oestrogen Receptor-Positive, HER2-Negative, Invasive Breast Cancer.
    PLoS One. 2016;11:e0158461.
    >> Share

  315. MA Y, Yin F, Zhang T, Zhou XA, et al
    Selection of the Maximum Spatial Cluster Size of the Spatial Scan Statistic by Using the Maximum Clustering Set-Proportion Statistic.
    PLoS One. 2016;11:e0147918.
    >> Share

  316. GOGOI P, Sepehri S, Zhou Y, Gorin MA, et al
    Development of an Automated and Sensitive Microfluidic Device for Capturing and Characterizing Circulating Tumor Cells (CTCs) from Clinical Blood Samples.
    PLoS One. 2016;11:e0147400.
    >> Share

  317. MARVIBAIGI M, Amini N, Supriyanto E, Abdul Majid FA, et al
    Antioxidant Activity and ROS-Dependent Apoptotic Effect of Scurrula ferruginea (Jack) Danser Methanol Extract in Human Breast Cancer Cell MDA-MB-231.
    PLoS One. 2016;11:e0158942.
    >> Share

  318. YU C, Wang J
    A Physical Mechanism and Global Quantification of Breast Cancer.
    PLoS One. 2016;11:e0157422.
    >> Share

  319. THAKUR S, Grover RK, Gupta S, Yadav AK, et al
    Identification of Specific miRNA Signature in Paired Sera and Tissue Samples of Indian Women with Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0158946.
    >> Share

  320. KLOTEN V, Schlensog M, Eschenbruch J, Gasthaus J, et al
    Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
    PLoS One. 2016;11:e0159073.
    >> Share

  321. BAUR B, Bozdag S
    A Feature Selection Algorithm to Compute Gene Centric Methylation from Probe Level Methylation Data.
    PLoS One. 2016;11:e0148977.
    >> Share

  322. DEVLIN KL, Sanford T, Harrison LM, LeBourgeois P, et al
    Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer.
    PLoS One. 2016;11:e0159686.
    >> Share

  323. QIU J, Guan J, Yang X, Wu J, et al
    Quality of Life and Psychological State in Chinese Breast Cancer Patients Who Received BRCA1/2 Genetic Testing.
    PLoS One. 2016;11:e0158531.
    >> Share

  324. PEREZ-PEREZ A, Sanchez-Jimenez F, Vilarino-Garcia T, de la Cruz L, et al
    Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells.
    PLoS One. 2016;11:e0158218.
    >> Share

  325. ONER C, Turgut Cosan D, Colak E
    Estrogen and Androgen Hormone Levels Modulate the Expression of PIWI Interacting RNA in Prostate and Breast Cancer.
    PLoS One. 2016;11:e0159044.
    >> Share

  326. TAVAKOLI TABA S, Hossain L, Heard R, Brennan P, et al
    Personal and Network Dynamics in Performance of Knowledge Workers: A Study of Australian Breast Radiologists.
    PLoS One. 2016;11:e0150186.
    >> Share

  327. MU WJ, Zhong WJ, Yao JY, Li LJ, et al
    Ultrasonic Elastography Research Based on a Multicenter Study: Adding Strain Ratio after 5-Point Scoring Evaluation or Not.
    PLoS One. 2016;11:e0148330.
    >> Share

  328. ASANO Y, Kashiwagi S, Onoda N, Noda S, et al
    Platelet-Lymphocyte Ratio as a Useful Predictor of the Therapeutic Effect of Neoadjuvant Chemotherapy in Breast Cancer.
    PLoS One. 2016;11:e0153459.
    >> Share

  329. HE S, Wang M, Yang Z, Zhang J, et al
    Comparison of 18F-FES, 18F-FDG, and 18F-FMISO PET Imaging Probes for Early Prediction and Monitoring of Response to Endocrine Therapy in a Mouse Xenograft Model of ER-Positive Breast Cancer.
    PLoS One. 2016;11:e0159916.
    >> Share

  330. LORSY E, Topuz AS, Geisler C, Stahl S, et al
    Loss of Dickkopf 3 Promotes the Tumorigenesis of Basal Breast Cancer.
    PLoS One. 2016;11:e0160077.
    >> Share

  331. STOCKER A, Hilbers ML, Gauthier C, Grogg J, et al
    HER2/CEP17 Ratios and Clinical Outcome in HER2-Positive Early Breast Cancer Undergoing Trastuzumab-Containing Therapy.
    PLoS One. 2016;11:e0159176.
    >> Share

  332. CHEN J, Yang C, Guo B, Sena ES, et al
    The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0158240.
    >> Share

  333. RIBE AR, Laurberg T, Laursen TM, Charles M, et al
    Ten-Year Mortality after a Breast Cancer Diagnosis in Women with Severe Mental Illness: A Danish Population-Based Cohort Study.
    PLoS One. 2016;11:e0158013.
    >> Share

  334. POSSO M, Carles M, Rue M, Puig T, et al
    Cost-Effectiveness of Double Reading versus Single Reading of Mammograms in a Breast Cancer Screening Programme.
    PLoS One. 2016;11:e0159806.
    >> Share

  335. YOON H, Yoon D, Yun M, Choi JS, et al
    Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRI.
    PLoS One. 2016;11:e0159949.
    >> Share

  336. IGNATIADIS M, Zardavas D, Lemort M, Wilke C, et al
    Feasibility Study of EndoTAG-1, a Tumor Endothelial Targeting Agent, in Combination with Paclitaxel followed by FEC as Induction Therapy in HER2-Negative Breast Cancer.
    PLoS One. 2016;11:e0154009.
    >> Share

  337. TODOROVA VK, Makhoul I, Siegel ER, Wei J, et al
    Biomarkers for Presymptomatic Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    PLoS One. 2016;11:e0160224.
    >> Share

  338. LINHER-MELVILLE K, Nashed MG, Ungard RG, Haftchenary S, et al
    Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.
    PLoS One. 2016;11:e0161202.
    >> Share

  339. WULANINGSIH W, Holmberg L, Abeler-Dorner L, Ng T, et al
    Correction: Associations of C-Reactive Protein, Granulocytes and Granulocyte-to-Lymphocyte Ratio with Mortality from Breast Cancer in Non-Institutionalized American Women.
    PLoS One. 2016;11:e0161418.
    >> Share

  340. HENDERSON MC, Hollingsworth AB, Gordon K, Silver M, et al
    Integration of Serum Protein Biomarker and Tumor Associated Autoantibody Expression Data Increases the Ability of a Blood-Based Proteomic Assay to Identify Breast Cancer.
    PLoS One. 2016;11:e0157692.
    >> Share

  341. GOMEZ-ACEBO I, Dierssen-Sotos T, Palazuelos C, Perez-Gomez B, et al
    The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.
    PLoS One. 2016;11:e0159672.
    >> Share

  342. CHEN X, Zhong SL, Lu P, Wang DD, et al
    miR-4443 Participates in the Malignancy of Breast Cancer.
    PLoS One. 2016;11:e0160780.
    >> Share

  343. LEDGER AE, Scurr ED, Hughes J, Macdonald A, et al
    Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular Tissue.
    PLoS One. 2016;11:e0152152.
    >> Share

  344. KATAYAMA K, Narimatsu H
    Prediction of Female Breast Cancer Incidence among the Aging Society in Kanagawa, Japan.
    PLoS One. 2016;11:e0159913.
    >> Share

  345. FANI S, Dehghan F, Karimian H, Mun Lo K, et al
    Monobenzyltin Complex C1 Induces Apoptosis in MCF-7 Breast Cancer Cells through the Intrinsic Signaling Pathway and through the Targeting of MCF-7-Derived Breast Cancer Stem Cells via the Wnt/beta-Catenin Signaling Pathway.
    PLoS One. 2016;11:e0160836.
    >> Share

  346. VETA M, van Diest PJ, Jiwa M, Al-Janabi S, et al
    Mitosis Counting in Breast Cancer: Object-Level Interobserver Agreement and Comparison to an Automatic Method.
    PLoS One. 2016;11:e0161286.
    >> Share

  347. XU T, Le TD, Liu L, Wang R, et al
    Identifying Cancer Subtypes from miRNA-TF-mRNA Regulatory Networks and Expression Data.
    PLoS One. 2016;11:e0152792.
    >> Share

  348. TELLAROLI P, Bazzi M, Donato M, Brazzale AR, et al
    Cross-Clustering: A Partial Clustering Algorithm with Automatic Estimation of the Number of Clusters.
    PLoS One. 2016;11:e0152333.
    >> Share

  349. KROIGARD AB, Thomassen M, Laenkholm AV, Kruse TA, et al
    Evaluation of Nine Somatic Variant Callers for Detection of Somatic Mutations in Exome and Targeted Deep Sequencing Data.
    PLoS One. 2016;11:e0151664.
    >> Share

  350. NYBAKKEN GE, Bala R, Gratzinger D, Jones CD, et al
    Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.
    PLoS One. 2016;11:e0151735.
    >> Share

  351. GUTNIK L, Moses A, Stanley C, Tembo T, et al
    From Community Laywomen to Breast Health Workers: A Pilot Training Model to Implement Clinical Breast Exam Screening in Malawi.
    PLoS One. 2016;11:e0151389.
    >> Share

  352. KIM HS, Park S, Koo JS, Kim S, et al
    Risk Factors Associated with Discordant Ki-67 Levels between Preoperative Biopsy and Postoperative Surgical Specimens in Breast Cancers.
    PLoS One. 2016;11:e0151054.
    >> Share

  353. SHERMAN ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, et al
    Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.
    PLoS One. 2016;11:e0160966.
    >> Share

  354. HORNE HN, Chung CC, Zhang H, Yu K, et al
    Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
    PLoS One. 2016;11:e0160316.
    >> Share

  355. LIU J, Sieuwerts AM, Look MP, van der Vlugt-Daane M, et al
    The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
    PLoS One. 2016;11:e0161731.
    >> Share

  356. SILVA VL, Ferreira D, Nobrega FL, Martins IM, et al
    Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0161290.
    >> Share

  357. MILLS D, Gomberawalla A, Gordon EJ, Tondre J, et al
    Examination of Duct Physiology in the Human Mammary Gland.
    PLoS One. 2016;11:e0150653.
    >> Share

  358. ZHANG W, Le TD, Liu L, Zhou ZH, et al
    Predicting miRNA Targets by Integrating Gene Regulatory Knowledge with Expression Profiles.
    PLoS One. 2016;11:e0152860.
    >> Share

  359. MOREL V, Joly D, Villatte C, Dubray C, et al
    Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients.
    PLoS One. 2016;11:e0152741.
    >> Share

  360. FISKAA T, Knutsen E, Nikolaisen MA, Jorgensen TE, et al
    Distinct Small RNA Signatures in Extracellular Vesicles Derived from Breast Cancer Cell Lines.
    PLoS One. 2016;11:e0161824.
    >> Share

  361. MA X, Wang X, Huang J, Chen Y, et al
    Bevacizumab Addition in Neoadjuvant Treatment Increases the Pathological Complete Response Rates in Patients with HER-2 Negative Breast Cancer Especially Triple Negative Breast Cancer: A Meta-Analysis.
    PLoS One. 2016;11:e0160148.
    >> Share

  362. ENNOUR-IDRISSI K, Tetu B, Maunsell E, Poirier B, et al
    Association of Telomere Length with Breast Cancer Prognostic Factors.
    PLoS One. 2016;11:e0161903.
    >> Share

  363. NORTON N, Advani PP, Serie DJ, Geiger XJ, et al
    Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors.
    PLoS One. 2016;11:e0153411.
    >> Share

  364. YANG SN, Li FJ, Chen JM, Zhang G, et al
    Kinetic Curve Type Assessment for Classification of Breast Lesions Using Dynamic Contrast-Enhanced MR Imaging.
    PLoS One. 2016;11:e0152827.
    >> Share

  365. CHAPA J, An G, Kulkarni SA
    Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model.
    PLoS One. 2016;11:e0152298.
    >> Share

  366. BENNANI-BAITI B, Dietzel M, Baltzer PA
    Correction: MRI Background Parenchymal Enhancement Is Not Associated with Breast Cancer.
    PLoS One. 2016;11:e0162936.
    >> Share

  367. GENG C, Chen X, Pan X, Li J, et al
    The Feasibility and Accuracy of Sentinel Lymph Node Biopsy in Initially Clinically Node-Negative Breast Cancer after Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
    PLoS One. 2016;11:e0162605.
    >> Share

  368. KIM HS, Jung M, Choi SK, Moon WK, et al
    Different Biological Action of Oleic Acid in ALDHhigh and ALDHlow Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer.
    PLoS One. 2016;11:e0160835.
    >> Share

  369. SCHERER SD, Bauer J, Schmaus A, Neumaier C, et al
    TGF-beta1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT).
    PLoS One. 2016;11:e0162221.
    >> Share

  370. TANG S, Wei L, Sun Y, Zhou F, et al
    CA153 in Breast Secretions as a Potential Molecular Marker for Diagnosing Breast Cancer: A Meta Analysis.
    PLoS One. 2016;11:e0163030.
    >> Share

  371. VITALI F, Cohen LD, Demartini A, Amato A, et al
    A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0162407.
    >> Share

  372. WANG Q, Liu L, Li H, Tao P, et al
    Effects of High-Order Interactions among IGFBP-3 Genetic Polymorphisms, Body Mass Index and Soy Isoflavone Intake on Breast Cancer Susceptibility.
    PLoS One. 2016;11:e0162970.
    >> Share

  373. KRISHNAN P, Ghosh S, Wang B, Heyns M, et al
    Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.
    PLoS One. 2016;11:e0162622.
    >> Share

  374. FUKADA I, Araki K, Kobayashi K, Shibayama T, et al
    Predictive Factors and Value of ypN+ after Neoadjuvant Chemotherapy in Clinically Lymph Node-Negative Breast Cancer.
    PLoS One. 2016;11:e0162616.
    >> Share

  375. FAN LC, Jeng YM, Lu YT, Lien HC, et al
    SPOCK1 Is a Novel Transforming Growth Factor-beta-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.
    PLoS One. 2016;11:e0162933.
    >> Share

  376. SUN X, Li Y, Zheng M, Zuo W, et al
    MicroRNA-223 Increases the Sensitivity of Triple-Negative Breast Cancer Stem Cells to TRAIL-Induced Apoptosis by Targeting HAX-1.
    PLoS One. 2016;11:e0162754.
    >> Share

  377. BRADFORD JR, Cox A, Bernard P, Camp NJ, et al
    Consensus Analysis of Whole Transcriptome Profiles from Two Breast Cancer Patient Cohorts Reveals Long Non-Coding RNAs Associated with Intrinsic Subtype and the Tumour Microenvironment.
    PLoS One. 2016;11:e0163238.
    >> Share

  378. KOTOULA V, Lakis S, Vlachos IS, Giannoulatou E, et al
    Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
    PLoS One. 2016;11:e0163138.
    >> Share

  379. PUCHALAPALLI M, Zeng X, Mu L, Anderson A, et al
    NSG Mice Provide a Better Spontaneous Model of Breast Cancer Metastasis than Athymic (Nude) Mice.
    PLoS One. 2016;11:e0163521.
    >> Share

  380. ZHANG ZQ, Cao Z, Liu C, Li R, et al
    MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer.
    PLoS One. 2016;11:e0163446.
    >> Share

  381. LEE MH, Jung SY, Kang SH, Song EJ, et al
    The Significance of Serum HER2 Levels at Diagnosis on Intrinsic Subtype-Specific Outcome of Operable Breast Cancer Patients.
    PLoS One. 2016;11:e0163370.
    >> Share

  382. CHAE JW, Ng T, Yeo HL, Shwe M, et al
    Impact of TNF-alpha (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
    PLoS One. 2016;11:e0164204.
    >> Share

  383. STAVRIDI F, Kalogeras KT, Pliarchopoulou K, Wirtz RM, et al
    Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study.
    PLoS One. 2016;11:e0164013.
    >> Share

  384. KAWIAK A, Domachowska A
    Plumbagin Suppresses the Invasion of HER2-Overexpressing Breast Cancer Cells through Inhibition of IKKalpha-Mediated NF-kappaB Activation.
    PLoS One. 2016;11:e0164064.
    >> Share

  385. SAGARA A, Igarashi K, Otsuka M, Karasawa T, et al
    Intrinsic Resistance to 5-Fluorouracil in a Brain Metastatic Variant of Human Breast Cancer Cell Line, MDA-MB-231BR.
    PLoS One. 2016;11:e0164250.
    >> Share

  386. HORIMOTO Y, Arakawa A, Sasahara N, Tanabe M, et al
    Combination of Cancer Stem Cell Markers CD44 and CD24 Is Superior to ALDH1 as a Prognostic Indicator in Breast Cancer Patients with Distant Metastases.
    PLoS One. 2016;11:e0165253.
    >> Share

  387. LIU X, Feng D, Liu D, Wang S, et al
    Dissecting the Origin of Breast Cancer Subtype Stem Cell and the Potential Mechanism of Malignant Transformation.
    PLoS One. 2016;11:e0165001.
    >> Share

  388. LAWRENCE CL, Baldwin AS
    Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0165005.
    >> Share

  389. HREBIEN S, O'Leary B, Beaney M, Schiavon G, et al
    Reproducibility of Digital PCR Assays for Circulating Tumor DNA Analysis in Advanced Breast Cancer.
    PLoS One. 2016;11:e0165023.
    >> Share

  390. FU J, Wu L, Jiang M, Li D, et al
    Clinical Nomogram for Predicting Survival Outcomes in Early Mucinous Breast Cancer.
    PLoS One. 2016;11:e0164921.
    >> Share

  391. SLAOUI M, Mouh FZ, Ghanname I, Razine R, et al
    Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution.
    PLoS One. 2016;11:e0164841.
    >> Share

  392. FORTENBERRY YM, Brandal SM, Carpentier G, Hemani M, et al
    Intracellular Expression of PAI-1 Specific Aptamers Alters Breast Cancer Cell Migration, Invasion and Angiogenesis.
    PLoS One. 2016;11:e0164288.
    >> Share

  393. ZHANG ZC, Xu QN, Lin SL, Li XY, et al
    Capecitabine in Combination with Standard (Neo)Adjuvant Regimens in Early Breast Cancer: Survival Outcome from a Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2016;11:e0164663.
    >> Share

  394. GONZALEZ-BENGTSSON A, Asadi A, Gao H, Dahlman-Wright K, et al
    Estrogen Enhances the Expression of the Polyunsaturated Fatty Acid Elongase Elovl2 via ERalpha in Breast Cancer Cells.
    PLoS One. 2016;11:e0164241.
    >> Share

  395. HAJIEBRAHIMI M, Montgomery S, Burkill S, Bahmanyar S, et al
    Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
    PLoS One. 2016;11:e0165027.
    >> Share

  396. ZHANG Z, Luo G, Tang H, Cheng C, et al
    Prognostic Significance of High VEGF-C Expression for Patients with Breast Cancer: An Update Meta Analysis.
    PLoS One. 2016;11:e0165725.
    >> Share

  397. HAN YJ, Zhang J, Zheng Y, Huo D, et al
    Genetic and Epigenetic Regulation of TOX3 Expression in Breast Cancer.
    PLoS One. 2016;11:e0165559.
    >> Share

  398. HYUN SH, Ahn HK, Lee JH, Choi JY, et al
    Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.
    PLoS One. 2016;11:e0165814.
    >> Share

  399. CHEN HL, Zhou MQ, Tian W, Meng KX, et al
    Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database.
    PLoS One. 2016;11:e0165409.
    >> Share

  400. GREGORIO AC, Fonseca NA, Moura V, Lacerda M, et al
    Inoculated Cell Density as a Determinant Factor of the Growth Dynamics and Metastatic Efficiency of a Breast Cancer Murine Model.
    PLoS One. 2016;11:e0165817.
    >> Share

  401. CHEN B, Dai D, Tang H, Ai X, et al
    Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer.
    PLoS One. 2016;11:e0165133.
    >> Share

  402. SHIOTA T, Miyasato Y, Ohnishi K, Yamamoto-Ibusuki M, et al
    The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
    PLoS One. 2016;11:e0166680.
    >> Share

  403. HANIEH H, Mohafez O, Hairul-Islam VI, Alzahrani A, et al
    Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells.
    PLoS One. 2016;11:e0167650.
    >> Share

  404. GROSSET AA, Poirier F, Gaboury L, St-Pierre Y, et al
    Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
    PLoS One. 2016;11:e0166731.
    >> Share

  405. SCOTT CM, Joo JE, O'Callaghan N, Buchanan DD, et al
    Methylation of Breast Cancer Predisposition Genes in Early-Onset Breast Cancer: Australian Breast Cancer Family Registry.
    PLoS One. 2016;11:e0165436.
    >> Share

  406. WU Z, Liu Y, Li X, Li X, et al
    Resilience and Associated Factors among Mainland Chinese Women Newly Diagnosed with Breast Cancer.
    PLoS One. 2016;11:e0167976.
    >> Share

  407. GERNAAT SA, Isgum I, de Vos BD, Takx RA, et al
    Automatic Coronary Artery Calcium Scoring on Radiotherapy Planning CT Scans of Breast Cancer Patients: Reproducibility and Association with Traditional Cardiovascular Risk Factors.
    PLoS One. 2016;11:e0167925.
    >> Share

  408. VAN HELMOND N, Steegers MA, Filippini-de Moor GP, Vissers KC, et al
    Hyperalgesia and Persistent Pain after Breast Cancer Surgery: A Prospective Randomized Controlled Trial with Perioperative COX-2 Inhibition.
    PLoS One. 2016;11:e0166601.
    >> Share

  409. TANINO H, Kosaka Y, Nishimiya H, Tanaka Y, et al
    BRCAness and Prognosis in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    PLoS One. 2016;11:e0165721.
    >> Share

  410. YEH TC, Huang TT, Yeh TS, Chen YR, et al
    miR-151-3p Targets TWIST1 to Repress Migration of Human Breast Cancer Cells.
    PLoS One. 2016;11:e0168171.
    >> Share

  411. PARK SY, Choi CH, Park JM, Chun M, et al
    A Patient-Specific Polylactic Acid Bolus Made by a 3D Printer for Breast Cancer Radiation Therapy.
    PLoS One. 2016;11:e0168063.
    >> Share

  412. HELLWIG B, Madjar K, Edlund K, Marchan R, et al
    Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.
    PLoS One. 2016;11:e0167585.
    >> Share

  413. FERNANDEZ-GALLARDO M, Gonzalez-Ramirez R, Sandoval A, Felix R, et al
    Adenosine Stimulate Proliferation and Migration in Triple Negative Breast Cancer Cells.
    PLoS One. 2016;11:e0167445.
    >> Share

  414. KOTWINSKI P, Smith G, Cooper J, Sanders J, et al
    Body Surface Area and Baseline Blood Pressure Predict Subclinical Anthracycline Cardiotoxicity in Women Treated for Early Breast Cancer.
    PLoS One. 2016;11:e0165262.
    >> Share

  415. KANG EJ, Seo JH, Kim LY, Park GU, et al
    Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study.
    PLoS One. 2016;11:e0168469.
    >> Share

  416. LIU H, Wang G, Yang L, Qu J, et al
    Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/beta-Catenin Pathway.
    PLoS One. 2016;11:e0168406.
    >> Share

  417. TOKUNAGA E, Yamashita N, Tanaka K, Inoue Y, et al
    Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women.
    PLoS One. 2016;11:e0168090.
    >> Share

  418. MORI H, Kubo M, Nishimura R, Osako T, et al
    BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer.
    PLoS One. 2016;11:e0167016.
    >> Share

  419. LIN J, Chen DR, Wang YF, Lai HW, et al
    Oncoplastic Surgery for Upper/Upper Inner Quadrant Breast Cancer.
    PLoS One. 2016;11:e0168434.
    >> Share

  420. FARAJI A, Dehghan Manshadi HR, Mobaraki M, Zare M, et al
    Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients.
    PLoS One. 2016;11:e0168519.
    >> Share

  421. WU ZH, Lin C, Liu MM, Zhang J, et al
    Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway.
    PLoS One. 2016;11:e0169230.
    >> Share

  422. GHOSH K, De S, Das S, Mukherjee S, et al
    Withaferin A Induces ROS-Mediated Paraptosis in Human Breast Cancer Cell-Lines MCF-7 and MDA-MB-231.
    PLoS One. 2016;11:e0168488.
    >> Share

  423. JIAO C, Cui L, Ma A, Li N, et al
    Elevated Serum Levels of Retinol-Binding Protein 4 Are Associated with Breast Cancer Risk: A Case-Control Study.
    PLoS One. 2016;11:e0167498.
    >> Share

  424. CAMPBELL TM, Castro MA, Ponder BA, Meyer KB, et al
    Identification of Post-Transcriptional Modulators of Breast Cancer Transcription Factor Activity Using MINDy.
    PLoS One. 2016;11:e0168770.
    >> Share

  425. REINERI S, Agati S, Miano V, Sani M, et al
    A Novel Functional Domain of Tab2 Involved in the Interaction with Estrogen Receptor Alpha in Breast Cancer Cells.
    PLoS One. 2016;11:e0168639.
    >> Share

  426. DIESSNER J, Wischnewsky M, Blettner M, Hausler S, et al
    Do Patients with Luminal A Breast Cancer Profit from Adjuvant Systemic Therapy? A Retrospective Multicenter Study.
    PLoS One. 2016;11:e0168730.
    >> Share

  427. KAZMIERCZAK PM, Todica A, Gildehaus FJ, Hirner-Eppeneder H, et al
    68Ga-TRAP-(RGD)3 Hybrid Imaging for the In Vivo Monitoring of alphavss3-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer.
    PLoS One. 2016;11:e0168248.
    >> Share

  428. BURKE NJ, Napoles TM, Banks PJ, Orenstein FS, et al
    Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients.
    PLoS One. 2016;11:e0168383.
    >> Share

  429. FERRARIO C, Strepponi I, Esfahani K, Charamis H, et al
    Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer.
    PLoS One. 2016;11:e0167906.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016